While regulatory controls on methadone(Drug information on methadone) clinics for opioid dependence resulted in treatment being physically and functionally isolated from conventional medical care, the delivery of an office-based treatment of buprenorphine(Drug information on buprenorphine)(Subutex) and the buprenorphine/naloxone combination product (Suboxone) over the last decade has facilitated the return of treatment to “mainstream medicine both for psychiatry and primary care,” said John A Renner, Jr, MD, Associate Professor of Psychiatry at Boston University School of Medicine.
read more : http://www.psychiatrictimes.com/conference-reports/apa2012/content/article/10168/2070904
